Yves Dondelinger

3.7k total citations · 1 hit paper
21 papers, 2.7k citations indexed

About

Yves Dondelinger is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yves Dondelinger has authored 21 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Yves Dondelinger's work include Cell death mechanisms and regulation (18 papers), NF-κB Signaling Pathways (12 papers) and interferon and immune responses (7 papers). Yves Dondelinger is often cited by papers focused on Cell death mechanisms and regulation (18 papers), NF-κB Signaling Pathways (12 papers) and interferon and immune responses (7 papers). Yves Dondelinger collaborates with scholars based in Belgium, United States and United Kingdom. Yves Dondelinger's co-authors include Mathieu J.M. Bertrand, Peter Vandenabeele, John Bertin, Peter J. Gough, Sasker Grootjans, Tom Delanghe, Inge Bruggeman, Paco Hulpiau, Ria Roelandt and Emmanuel Dejardin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Yves Dondelinger

21 papers receiving 2.7k citations

Hit Papers

MLKL Compromises Plasma Membrane Integrity by Binding to ... 2014 2026 2018 2022 2014 200 400 600

Peers

Yves Dondelinger
Irene L. Ch’en United States
Ryan M. Genga United States
Claudia Langlais United Kingdom
David Moquin United States
Tathagat Dutta Ray United States
Juan Lin China
Yves Dondelinger
Citations per year, relative to Yves Dondelinger Yves Dondelinger (= 1×) peers Duanwu Zhang

Countries citing papers authored by Yves Dondelinger

Since Specialization
Citations

This map shows the geographic impact of Yves Dondelinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Dondelinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Dondelinger more than expected).

Fields of papers citing papers by Yves Dondelinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Dondelinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Dondelinger. The network helps show where Yves Dondelinger may publish in the future.

Co-authorship network of co-authors of Yves Dondelinger

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Dondelinger. A scholar is included among the top collaborators of Yves Dondelinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Dondelinger. Yves Dondelinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dondelinger, Yves, et al.. (2023). NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis. Cell Death and Disease. 14(11). 755–755. 36 indexed citations
2.
Puylaert, Pauline, Yves Dondelinger, Tom Delanghe, et al.. (2022). The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach. Biomedicines. 10(5). 1016–1016. 5 indexed citations
3.
Dondelinger, Yves, et al.. (2022). Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells. Frontiers in Immunology. 13. 1067164–1067164. 12 indexed citations
4.
Delanghe, Tom, Dario Priem, Samya Van Coillie, et al.. (2021). Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor. Cell Death and Disease. 12(7). 699–699. 24 indexed citations
5.
Simpson, Jennifer, Zhixuan Loh, Md Ashik Ullah, et al.. (2020). Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells. American Journal of Respiratory and Critical Care Medicine. 201(11). 1358–1371. 89 indexed citations
6.
Delanghe, Tom, Yves Dondelinger, & Mathieu J.M. Bertrand. (2020). RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events. Trends in Cell Biology. 30(3). 189–200. 108 indexed citations
7.
Dondelinger, Yves, Tom Delanghe, Dario Priem, et al.. (2019). Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nature Communications. 10(1). 1729–1729. 139 indexed citations
8.
Priem, Dario, Yves Dondelinger, & Mathieu J.M. Bertrand. (2018). Monitoring RIPK1 Phosphorylation in the TNFR1 Signaling Complex. Methods in molecular biology. 1857. 171–179. 3 indexed citations
9.
Dondelinger, Yves, Tom Delanghe, & Mathieu J.M. Bertrand. (2018). MK2 puts an additional brake on RIPK1 cytotoxic potential. Cell Death and Differentiation. 25(3). 457–459. 10 indexed citations
10.
Estornes, Yann, Yves Dondelinger, Kathrin Weber, et al.. (2018). N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis. Cell Death and Disease. 9(5). 494–494. 15 indexed citations
11.
Dondelinger, Yves, Tom Delanghe, Diego Rojas‐Rivera, et al.. (2017). MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nature Cell Biology. 19(10). 1237–1247. 162 indexed citations
12.
Dondelinger, Yves, Maurice Darding, Mathieu J.M. Bertrand, & Henning Walczak. (2016). Poly-ubiquitination in TNFR1-mediated necroptosis. Cellular and Molecular Life Sciences. 73(11-12). 2165–2176. 131 indexed citations
13.
Dondelinger, Yves, Paco Hulpiau, Yvan Saeys, Mathieu J.M. Bertrand, & Peter Vandenabeele. (2016). An evolutionary perspective on the necroptotic pathway. Trends in Cell Biology. 26(10). 721–732. 122 indexed citations
14.
Grootjans, Sasker, Behrouz Hassannia, Iris Delrue, et al.. (2016). A real-time fluorometric method for the simultaneous detection of cell death type and rate. Nature Protocols. 11(8). 1444–1454. 50 indexed citations
15.
Seo, Jinho, Eun‐Woo Lee, Yves Dondelinger, et al.. (2016). CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3. Nature Cell Biology. 18(3). 291–302. 153 indexed citations
16.
Dondelinger, Yves, Sandrine Jouan-Lanhouet, Tatyana Divert, et al.. (2015). NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. Molecular Cell. 60(1). 63–76. 344 indexed citations
17.
Dondelinger, Yves, Wim Declercq, Sylvie Montessuit, et al.. (2014). MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Reports. 7(4). 971–981. 663 indexed citations breakdown →
18.
Berghe, Tom Vanden, Sasker Grootjans, Vera Goossens, et al.. (2013). Determination of apoptotic and necrotic cell death in vitro and in vivo. Methods. 61(2). 117–129. 196 indexed citations
19.
Dondelinger, Yves, Miguel Aguileta, Sasker Grootjans, et al.. (2013). RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death and Differentiation. 20(10). 1381–1392. 252 indexed citations
20.
Duprez, Linde, Mathieu J.M. Bertrand, Tom Vanden Berghe, et al.. (2012). Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis. Journal of Biological Chemistry. 287(18). 14863–14872. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026